Difficulty
Easy
Candidate-reported interview insights
Allogene Therapeutics Interview Questions
Explore commonly reported questions, interview rounds, difficulty, duration, and candidate experiences at Allogene Therapeutics.
4.3 rating Biotech & Pharmaceuticals
Interview overview
Average rounds
3.2
Difficulty and candidate experience
Interview difficulty
easy50%
average50%
difficult0%
Candidate experience
positive66.7%
negative25%
neutral8.3%
Candidate-reported interview process
It started with a phone screen, then there were seven zoom meetings with nine people over two days. Everyone was friendly and professional, but it was very time consuming on my part.
The interview process was disappointing due to the low effort from the interviewers. One interviewer used generic questions they clearly found online, holding a printout during the interview. Another interviewer hadn't reviewed my resume and mistook me for someone else. This lack of preparation makes me question the actual work environment.
I first met with the hiring manager to go over the role. After that, I gave a seminar about my past research. Then, I had some more one-on-one interviews and finished with a group interview with the team.
Common Allogene Therapeutics interview questions
A focused selection of the most detailed candidate-submitted questions.
- 1
What type of business partner interactions do you have in your current role
- 2
What projects have you completed using statistical methodology?
- 3
How do you think you can contribute to the company if hired?
- 4
Why are you looking to leave your current position?
Interview question formats
Behavioral52.2%
Technical34.8%
Presentation13%
Popular Allogene Therapeutics roles
- Scientist7 reports
- Associate2 reports
- Data Scientist1 report
- Manager1 report
- Finance1 report
Ready to prepare for Allogene Therapeutics?
Practice technical, system design, and behavioral questions with Zitlee.
Interview information is based on candidate reports and may not represent the current official hiring process of Allogene Therapeutics.